Indianapolis and Encino, Jan. 19, 2016 — PTS Diagnostics, Infopia Co., LTD, Infopia America LLC, and Jant Pharmacal Corporation today announced the settlement of PTS Diagnostics’ claims that Infopia’s HDL-cholesterol testing products sold by Jant in the United States infringe PTS Diagnostics’ U.S. patent no. 7,087,397. The settlement was entered into by the parties to amicably resolve pending litigation without admission of liability or lack of liability by any party.